(Q43923057)

28 November 2017

title

Duodenal levodopa infusion in Parkinson's disease--long-term experience (English)

1 reference

28 November 2017

1 reference

1 reference

Nilsson D

1

1 reference

28 November 2017

Nyholm D

series ordinal

2

1 reference

28 November 2017

Aquilonius SM

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Acta Neurologica Scandinavica

28 November 2017

published in

1 reference

28 November 2017

volume

104

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

343-348

1 reference

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Disability profiles and objective quantitative assessment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Neostriatal mechanisms in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Continuous levodopa infusions to treat complex dystonia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Objective measurement of motor disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Control of on/off phenomenon by continuous intravenous infusion of levodopa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the antiparkinsonian effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.00153.X

7 January 2021

10.1034/J.1600-0404.2001.00153.X

Identifiers

DOI

1 reference

28 November 2017

1 reference